The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Proxeon develops state-of-the-art solutions to solve many of the scientific and technical challenges that are faced by those working in the field of proteomics. The company's core competencies are in the areas of mass spectrometry, protein analysis, hardware and software design for proteome analysis.
A highly specialized research and development company that focuses on developing medical diagnostic devices. The range of skills within RD Support enables efficient Design for Manufacture (DFM) product development.